Position in STRO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$214,348
+$5,698 QoQ
Shares Held
8,605
-52.3% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in STRO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $214,348 | 8,605 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $208,650 | 18,034 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $308,369 | 354,449 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $719,027 | 1,012,716 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $858,594 | 1,320,917 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $210,838 | 114,587 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,126,359 | 325,538 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $830,701 | 283,516 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $202,394 | 35,822 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $358,755 | 83,626 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $82,440 | 23,758 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $379,909 | 81,701 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,818,875 | 393,696 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,600,696 | 198,106 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,066,021 | 192,076 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $309,458 | 59,397 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $190,506 | 23,176 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $274,263 | 14,519 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $971,169 | 42,670 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $325,845 | 15,009 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||